These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25477145)

  • 1. Exact calculation of power and sample size in bioequivalence studies using two one-sided tests.
    Shen M; Russek-Cohen E; Slud EV
    Pharm Stat; 2015; 14(2):95-101. PubMed ID: 25477145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple formula for sample size calculation in equivalence studies.
    Zhang P
    J Biopharm Stat; 2003 Aug; 13(3):529-38. PubMed ID: 12921399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size determination for equivalence assessment with multiple endpoints.
    Sun A; Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1203-14. PubMed ID: 25032845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach for sample size determination of average bioequivalence based on interval estimation.
    Chiang C; Hsiao CF
    Stat Med; 2017 Mar; 36(7):1068-1082. PubMed ID: 28070984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple testing for bioequivalence with pharmacokinetic data in 2 x 2 crossover designs.
    Chen YI; Huang CS
    Stat Med; 2009 Dec; 28(28):3567-79. PubMed ID: 19760611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two one-sided tests procedure for assessment of individual bioequivalence.
    Liu J; Chow SC
    J Biopharm Stat; 1997 Mar; 7(1):49-61. PubMed ID: 9056588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approximate approach to sample size determination in bioequivalence testing with multiple pharmacokinetic responses.
    Tsai CA; Huang CY; Liu JP
    Stat Med; 2014 Aug; 33(19):3300-17. PubMed ID: 24771655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A note on sample size determination for bioequivalence studies with high-order crossover designs.
    Chen KW; Chow SC; Li G
    J Pharmacokinet Biopharm; 1997 Dec; 25(6):753-65. PubMed ID: 9697082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalence assessment for interchangeability based on two-sided tests.
    Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1312-31. PubMed ID: 25032976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equivalence tests for interchangeability based on two one-sided probabilities.
    Dong X; Tsong Y; Shen M
    J Biopharm Stat; 2014; 24(6):1332-48. PubMed ID: 25033074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size determination in bioequivalence studies using statistical assurance.
    Ring A; Lang B; Kazaroho C; Labes D; Schall R; Schütz H
    Br J Clin Pharmacol; 2019 Oct; 85(10):2369-2377. PubMed ID: 31276603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter to the editor by the authors of Exact Calculation of Power and Sample Size in Bioequivalence Studies Using Two One-sided Tests, Pharmaceutical Statistics, DOI: 10.1002/pst.1666.
    Shen M; Russek-Cohen E; Slud EV
    Pharm Stat; 2015; 14(3):272. PubMed ID: 25807931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Average bioequivalence for two-sequence two-period crossover design with incomplete data.
    Lee JY; Kim BC; Park SG
    J Biopharm Stat; 2005; 15(5):857-67. PubMed ID: 16078389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power of the two one-sided tests procedure in bioequivalence.
    Phillips KF
    J Pharmacokinet Biopharm; 1990 Apr; 18(2):137-44. PubMed ID: 2348380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A note on sample size calculation for mean comparisons based on noncentral t-statistics.
    Chow SC; Shao J; Wang H
    J Biopharm Stat; 2002 Nov; 12(4):441-56. PubMed ID: 12477068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust and bootstrap testing procedures for bioequivalence.
    Shen CF; Iglewicz B
    J Biopharm Stat; 1994 Mar; 4(1):65-90. PubMed ID: 8019585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On statistical power for average bioequivalence testing under replicated crossover designs.
    Wan H; Chow SC
    J Biopharm Stat; 2002 Aug; 12(3):295-309. PubMed ID: 12448572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size determination in two-sided distribution-free treatment versus control multiple comparisons.
    Fan C; Zhang D
    J Biopharm Stat; 2013; 23(6):1308-29. PubMed ID: 24138434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size calculation for the Power Model for dose proportionality studies.
    Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
    Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of group sequential and fixed sample size designs for bioequivalence trials with highly variable drugs.
    Knahl SIE; Lang B; Fleischer F; Kieser M
    Eur J Clin Pharmacol; 2018 May; 74(5):549-559. PubMed ID: 29362819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.